Ethanol for Disinfection JP
CGR-JP-007 · MHLW — JP XVIII: Ethanol for Disinfection JP
Documented bibliographic addition; requires local scientific approval before use as a master formulation record.
Source formula
| Ingredient | Source quantity |
|---|---|
| Ethanol JP, 95.1–96.9% v/v at 15°C | 830 mL |
| Purified water | q.s. ad 1000 mL |
Quantities refer to the source batch. This website does not automatically scale formulas, assign doses or calculate BUD.
Description
Documented in sourceClear, colourless, volatile, flammable liquid, miscible with water.
References: [1]
Use and action
Partial evidenceEthanol preparation for disinfection as named by JP. This monograph does not prescribe a dose, contact time or efficacy against a specific microorganism.
References: [1]
Specifications
Documented in sourceFinal ethanol 76.9–81.4% v/v at 15°C. Relative density d15/15: 0.86027–0.87264. Clear, colourless solution. Comply with prescribed purity tests.
References: [1]
Light
Documented in sourceThe specific monograph requires light protection.
References: [1]
Air
Partial evidenceEthanol generates vapour; limit time in open vessels. Evaporation can change composition (editorial process assessment).
References: [5]
Water and solubility
Documented in sourceMiscible with water. Adding water changes strength; final volume adjustment and density verification are required.
References: [1]
Humidity
Not establishedNo specific finished-product information is established in the reviewed sources. Additional evidence is required before defining a specification.
References: [1]
Temperature
Not establishedNo specific finished-product information is established in the reviewed sources. Additional evidence is required before defining a specification.
References: [1]
pH and related incompatibilities
Not establishedNo specific finished-product information is established in the reviewed sources. Additional evidence is required before defining a specification.
References: [1]
Other incompatibilities
Partial evidenceEthanol is incompatible with strong oxidants.
References: [5]
Ingredient-specific information
Partial evidenceExact identities: Αιθανόλη JP, 95,1–96,9% v/v στους 15°C / Ethanol JP, 95.1–96.9% v/v at 15°C; Κεκαθαρμένο ύδωρ / Purified water. Use pharmacopoeial raw materials of the referenced edition, with CoA verification. Do not arbitrarily change salt, hydration state or strength. Record the actual q.s. amount in the batch.
References: [1]
Compounding conditions
Editorial checklistJP provides no specific numerical room limits for this formula. Define a local SOP covering suitable clean conditions, temperature control and contamination prevention. This is an editorial checklist.
Personal protective equipment
Partial evidenceClean protective clothing and head covering under AEMPS PN/L/PG/002/00. Use suitable gloves where contact is possible and respiratory/eye protection where powder handling requires it. Exact glove material, ventilation and respiratory protection must follow the SDS and local exposure assessment.
References: [4]
Risks and precautions
Partial evidenceFlammable vapour. Assess ventilation, ignition sources and the amount of solvent handled by the laboratory.
Ethanol: flammable vapour; control ignition sources and provide suitable ventilation. Final classification depends on concentration/mixture.
BUD rationale
Not establishedThe specific monograph provides no finished-product beyond-use period/BUD. No duration is assigned by assumption. Suitable stability evidence and responsible-pharmacist approval are required before release.
References: [1]
Bases and dependencies
Documented in sourceNo separate compound base is required in the explicit formula.
References: [1]
Equipment
Editorial checklistBalance with suitable resolution, mortar/spatula, suitable mixing vessels and final container. Add volumetric equipment for mL, a controlled water bath where melting is specified and a suitable filter where required. Analytical equipment follows the QC methods.
Preparation procedure
Partial evidence1. Verify JP-grade starting ethanol containing 95.1–96.9% v/v at 15°C.
2. Measure 830 mL and add purified water.
3. Mix and make up to a final volume of 1000 mL with water. Temperature equilibration before final volume adjustment is a local control for contraction/heating during mixing. Verify final strength by the official method.
Observations
Partial evidence830 mL of JP Ethanol does not mean 83% absolute ethanol. Do not substitute the same volume of anhydrous ethanol. The 24-month period in the adjacent Ethanol/Anhydrous Ethanol monograph is not transferred here.
References: [1]
Packaging
Partial evidenceTight, light-resistant container.
References: [1]
Labelling
editorial_specimenEthanol for Disinfection JP
Quantity: _____ · Batch: _____ · Prepared: _____ · Use by: _____
External use only. Storage: Keep tightly closed and protected from light. Control ignition sources because of ethanol. The specific monograph gives no numerical storage temperature.
Patient/directions or laboratory use: _____ · Pharmacy/telephone: _____
Flammable. Keep away from flames. Do not swallow.
Specimen for pharmacist adaptation; not a final approved label.
Quality control
Partial evidenceUse JP 2.56 relative density to verify concentration. Identification uses the two chemical reactions in the specific monograph. Purity follows Ethanol tests (clarity, acidity/alkalinity, volatile impurities by GC, evaporation residue), with a specific final-solution UV test: 5 cm cell, water blank; A240 ≤0.40, A250–260 ≤0.30, A270–340 ≤0.10 and a smooth curve over 235–340 nm. Execution requires the full referenced text.
Storage
Partial evidenceKeep tightly closed and protected from light. Control ignition sources because of ethanol. The specific monograph gives no numerical storage temperature.
Dispensing and directions
Partial evidenceLabel as a disinfectant preparation; not for drinking. Establish the permitted application and contact time separately. Do not infer marketing authorisation or a specific antimicrobial spectrum from this monograph alone.
References: [1]
Sources and traceability
- MHLW — JP XVIII: Ethanol for Disinfection JP
2021 · JP XVIII (2021), printed pp. 966–967; starting Ethanol pp. 964–965 · A1 official pharmacopoeia
Review date reported in supplied metadata: 2026-09-10
- MHLW — JP XVIII, General Rules for Preparations
2021 · 11-4 Ointments and 11-2 Cutaneous liquids, printed p. 20; Other Preparations 3 Spirits, p. 22; General Notices · A1 official pharmacopoeia
Review date reported in supplied metadata: 2026-09-10
- PN/L/FF/007/00 ELABORACIÓN DE SOLUCIONES
PN/L/FF/007/00 · §4.3 environment; §4.4 method; §4.6 controls · A2 official technical guidance
Review date reported in supplied metadata: 2026-09-10
- PN/L/PG/002/00 INDUMENTARIA
PN/L/PG/002/00 · Clothing and protective equipment · A2 official technical guidance
Review date reported in supplied metadata: 2026-09-10
- niosh_ethanol
Official agency page · Raw-material properties, handling and incompatibilities · A2 official technical guidance
Review date reported in supplied metadata: 2026-09-10
- AEMPS — Aviso legal
Policy checked 2026-09-10 · Reuse conditions · Rights policy, not clinical evidence
Review date reported in supplied metadata: 2026-09-10
- BOE — Real Decreto 1495/2011, artículos 7–10 y anexo
Policy checked 2026-09-10 · Reuse conditions · Rights policy, not clinical evidence
Review date reported in supplied metadata: 2026-09-10
- MHLW — Copyright and Public Data License policy
Policy checked 2026-09-10 · Reuse conditions · Rights policy, not clinical evidence
Review date reported in supplied metadata: 2026-09-10
- Digital Agency — Public Data License 1.0
Policy checked 2026-09-10 · Reuse conditions · Rights policy, not clinical evidence
Review date reported in supplied metadata: 2026-09-10
- PMDA — JP XVIII supplements and errata index
Supplement I 2022; II 2024; base errata March 2026 · Selected entries checked; no change to these four compositions identified · A1 official edition control
Review date reported in supplied metadata: 2026-09-10
Provenance and reuse
Source: Ministry of Health, Labour and Welfare, Japan, Japanese Pharmacopoeia XVIII, English edition 2021. Reuse under Public Data License 1.0 through the MHLW policy, with source attribution and changes identified. Greek translation, English summary/restructuring and editorial additions: Greek Formulary Sikalias, Stasinos Chr. Sikalias, compounding.gr. This is not an official translation or MHLW endorsement. The Japanese original prevails if it differs from the official English rendering. No logos or specially restricted third-party material are used. Supplementary AEMPS/CDC information is attributed separately. CDC/NIOSH sources are freely available from CDC; brief technical paraphrases imply no CDC endorsement.
SHA-256 of the supplied PDF: dd330e4c8c124359a8a5754069f91d59f44d77735de3177bff98fb2e64be7bc1